TABLE 3.
Incidence of local solicited adverse events during the day of vaccination and each of the consecutive 4 days after the first, second and third vaccination
| Local adverse events |
HBAI20 (n = 1,345 days) |
HBVaxPro®‐10 µg (n = 435 days) |
P value | |
|---|---|---|---|---|
| Pain at the injection site | Any | 440 (32.7%) | 81 (18.6%) | <.001 |
| Severe | 0 (0.0%) | 0 (0.0%) | — | |
| Impaired movement of injected arm | Any | 198 (14.7%) | 43 (9.9%) | .013 |
| Severe | 0 (0.0%) | 0 (0.0%) | — | |
| Redness | Any | 95 (7.06%) | 16 (3.7%) | .015 |
| Severe | 2 (0.1%) | 0 (0.0%) | 1.000 | |
| Swelling | Any | 79 (5.9%) | 25 (5.8%) | 1.000 |
| Severe | 1 (0.1%) | 0 (0.0%) | 1.000 | |
| Induration | Any | 106 (7.9%) | 24 (5.5%) | .123 |
| Severe | 1 (0.1%) | 0 (0.0%) | 1.000 |